Vande Pol S B, Howley P M
Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda Maryland 20892.
J Virol. 1995 Jan;69(1):395-402. doi: 10.1128/JVI.69.1.395-402.1995.
Papillomaviruses induce benign squamous epithelial lesions that infrequently are associated with uncontrolled growth or malignant conversion. The virus-encoded oncogenes are clearly under negative regulation since papillomaviruses can latently infect cells and since different levels of viral oncogene expression are seen within the layers of differentiating infected epitheliomas. We used bovine papillomavirus type 1 (BPV-1) to investigate the mechanisms involved in the negative regulation of transformation. We found that the following two distinct and interacting mechanisms negatively regulate BPV-1 transformation effected by virally encoded trans-acting factors: (i) E2 repressors suppress transformation by the E6 and E7 oncogenes, and (ii) E1 and the E2 transactivator suppress transformation by the E6, E7, and E5 oncogenes. These systems interact in that the E2 repressors function to relieve the transformation suppression effected by the E1 and E2 transactivator genes. A BPV-1 mutant that lacked E2 repressors and E1 had greatly augmented transformation capacity. Analysis of this mutant revealed that the enhanced transformation was due to expression of the E6 and E7 genes in the absence of E5, revealing a previously unappreciated potency and synergy for the BPV-1 E6 and E7 oncogenes.
乳头瘤病毒可诱发良性鳞状上皮病变,这些病变很少与生长失控或恶性转化相关。由于乳头瘤病毒能够潜伏感染细胞,并且在分化的感染上皮瘤各层中可见不同水平的病毒癌基因表达,因此病毒编码的癌基因显然处于负调控之下。我们利用1型牛乳头瘤病毒(BPV-1)来研究参与转化负调控的机制。我们发现以下两种不同且相互作用的机制对病毒编码的反式作用因子所介导的BPV-1转化进行负调控:(i)E2阻遏物通过E6和E7癌基因抑制转化,以及(ii)E1和E2反式激活因子通过E6、E7和E5癌基因抑制转化。这些系统相互作用,因为E2阻遏物的作用是解除由E1和E2反式激活因子基因所介导的转化抑制。一个缺乏E2阻遏物和E1的BPV-1突变体具有大大增强的转化能力。对该突变体的分析表明,增强的转化是由于在没有E5的情况下E6和E7基因的表达,揭示了BPV-1 E6和E7癌基因之前未被认识到的效力和协同作用。